BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25937258)

  • 1. Flavonoids as a scaffold for development of novel anti-angiogenic agents: An experimental and computational enquiry.
    Gacche RN; Meshram RJ; Shegokar HD; Gond DS; Kamble SS; Dhabadge VN; Utage BG; Patil KK; More RA
    Arch Biochem Biophys; 2015 Jul; 577-578():35-48. PubMed ID: 25937258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of selected flavonoids as antiangiogenic, anticancer, and radical scavenging agents: an experimental and in silico analysis.
    Gacche RN; Shegokar HD; Gond DS; Yang Z; Jadhav AD
    Cell Biochem Biophys; 2011 Dec; 61(3):651-63. PubMed ID: 21830125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydroxyl substitution of flavone on angiogenesis and free radical scavenging activities: a structure-activity relationship studies using computational tools.
    Rajesh G; Harshala S; Dhananjay G; Jadhav A; Vikram G
    Eur J Pharm Sci; 2010 Jan; 39(1-3):37-44. PubMed ID: 19874890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Characterization of 4-Anilino-6,7-Dimethoxy Quinazoline Derivatives as Potential Anti-Angiogenic Agents.
    Devegowda PS; Balaji KS; Prasanna DS; Swaroop TR; Kameshwar VH; Jayarama S; Siddalingaiah L; Rangappa KS
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1931-1941. PubMed ID: 28403784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of N-(4-(substituted)-3-(trifluoromethyl) phenyl) isobutyramides and their N-ethyl analogous as anticancer, anti-angiogenic & antioxidant agents: In vitro and in silico analysis.
    Sawant AS; Kamble SS; Pisal PM; Sawant SS; Hese SV; Bagul KT; Pinjari RV; Kamble VT; Meshram RJ; Gacche RN
    Comput Biol Chem; 2021 Jun; 92():107484. PubMed ID: 33865034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant, Anti-Inflammatory and Anticancer Activities of the Methanolic Extract of Thottea siliquosa: An In Vitro and In Silico Study.
    Koottasseri A; Babu A; Augustin A; Job JT; Narayanankutty A
    Recent Pat Anticancer Drug Discov; 2021; 16(3):436-444. PubMed ID: 33797378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
    Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
    Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids as RTK inhibitors and potential anticancer agents.
    Teillet F; Boumendjel A; Boutonnat J; Ronot X
    Med Res Rev; 2008 Sep; 28(5):715-45. PubMed ID: 18080331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus Dorstenia: gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol.
    Kuete V; Ngameni B; Wiench B; Krusche B; Horwedel C; Ngadjui BT; Efferth T
    Planta Med; 2011 Dec; 77(18):1984-9. PubMed ID: 21800276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of Hydroxyl Groups on the B-Ring of Flavonoids Affects Their Antioxidant Activity and Interaction with Phorbol Ester Binding Site of PKCδ C1B Domain: In Vitro and in Silico Studies.
    Kongpichitchoke T; Hsu JL; Huang TC
    J Agric Food Chem; 2015 May; 63(18):4580-6. PubMed ID: 25907027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship.
    Jeong JM; Choi CH; Kang SK; Lee IH; Lee JY; Jung H
    J Pharm Pharm Sci; 2007; 10(4):537-46. PubMed ID: 18261373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
    Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.
    Lv PC; Wang KR; Li QS; Chen J; Sun J; Zhu HL
    Bioorg Med Chem; 2010 Feb; 18(3):1117-23. PubMed ID: 20056425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
    Le Tourneau C; Vidal L; Siu LL
    Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
    Özcetin A; Aigner A; Bakowsky U
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis.
    Lee JH; Kim GH
    J Food Sci; 2010 Sep; 75(7):H212-7. PubMed ID: 21535545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant, antimicrobial, and anticancer activity of 3 Umbilicaria species.
    Kosanić M; Ranković B; Stanojković T
    J Food Sci; 2012 Jan; 77(1):T20-5. PubMed ID: 22260138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.